Clinical Trial Update: A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

View source ↗

Summary

A terminated trial sponsored by Sanofi comparing extended versus conventional duration of enoxaparin prophylaxis for preventing venous thromboembolism in acutel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Lovenox (enoxaparin)

Snippet

Sponsor: Sanofi | Conditions: Venous Thromboembolism | Status: TERMINATED